TimeScale Financial’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

TimeScale Financial’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$4.41K	Buy	189 +1	+0.5%	+$24	﹤0.01%	443
2023 Q1	$4.38K	Hold	188	–	–	﹤0.01%	437
2022 Q4	$4.97K	Hold	188	–	–	﹤0.01%	381
2022 Q3	$5K	Hold	188	–	–	﹤0.01%	381
2022 Q2	$5K	Hold	188	–	–	﹤0.01%	361
2022 Q1	$6K	Sell	188 -209	-53%	-$7.38K	﹤0.01%	362
2021 Q4	$17K	Buy	397 +2	+0.5%	+$95	﹤0.01%	247
2021 Q3	$20K	Hold	395	–	–	﹤0.01%	244
2021 Q2	$21K	Hold	395	–	–	0.01%	241
2021 Q1	$18K	Buy	395 +269	+213%	+$13.1K	﹤0.01%	277
2020 Q4	$6K	Hold	126	–	–	﹤0.01%	322
2020 Q3	$5K	Buy	+126	New	+$4.84K	﹤0.01%	352

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

TimeScale Financial's IDNA Position: Q2 2023 in Review

TimeScale Financial increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 0.53% in Q2 2023, buying an estimated $24 and bringing the position to 189 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

TimeScale Financial first reported a position in IDNA in Q3 2020 and has held it in 12 quarters since. The position peaked at $21K in Q2 2021. 67 funds tracked by Wall St. Rank hold IDNA as of Q2 2023.

TimeScale Financial held 189 shares of iShares Genomics Immunology and Healthcare ETF worth $4.41K as of Q2 2023.
TimeScale Financial bought 1 iShares Genomics Immunology and Healthcare ETF share in Q2 2023, an estimated $24.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #443 holding.
TimeScale Financial first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and has held it in 12 quarters since.
TimeScale Financial's iShares Genomics Immunology and Healthcare ETF position peaked at $21K in Q2 2021.
67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.